Trials / Available
AvailableNCT07497984
ITM11 Expanded Access Program
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- ITM Solucin GmbH · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
This Expanded Access Program (EAP) is intended to provide eligible participants with access to ITM-11 prior to approval by local regulatory authorities. Program availability is subject to country eligibility. The treating physician must determine, based on the individual patient´s medical history and the program eligibility criteria, whether the potential benefits outweigh the risks of treatment with an investigational therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ITM-11 | Intravenous (IV) infusion |
Timeline
- First posted
- 2026-03-27
- Last updated
- 2026-03-27
Source: ClinicalTrials.gov record NCT07497984. Inclusion in this directory is not an endorsement.